Skip to content
Sunday 9 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,901.09
+0.31%
DAX
26,319.45
+0.69%
CAC 40
8,714.93
+0.17%
STOXX 50
6,523.86
+0.33%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE

Patents

  • Triumph for Tesla as top court rules 5G licensing case should be heard in UK

    Lawsuit

    The UK’s highest court has given the green light for Tesla to revive a lawsuit over 5G licensing in its electric cars, after the case was previously dismissed by a panel of judges three years ago. Elon Musk’s carmaker, one of the largest global manufacturers of electric vehicles, sued Avanci, a Texan company that supplies [...]

    Tech billionaire Elon Musk has been asked to serve in Donald Trump’s cabinet. (Photo by Apu Gomes/Getty Images)
  • Lufthansa and aviation rivals clash in London court over power outlet profits

    Legal

    German airline Lufthansa is back in the London courts this week over its long-running patent infringement dispute with a US, a Japanese, and a French aircraft manufacturer. The legal battle stems back to 2017, when aircraft maintenance group Lufthansa Technik alleged that Astronics Advanced Electronic Systems, Panasonic, and Safran infringed its patent for high-voltage aircraft [...]

    Lufthansa aircraft on tarmac with logo visible, showcasing airlines fleet under clear sky in a business news context
  • Patent cliff fuels Novartis’ $1.5bn swoop for London biotech

    Healthcare

    Swiss pharmaceutical giant Novartis has agreed to buy London-based biotech Myricx Bio for up to $1.5bn (£1.1bn) as global drugmakers continue deploying billions into promising biotech firms ahead of an estimated $450bn wave of patent expiries over the next decade. The deal will see Novartis pay $1.1bn upfront, with a further $400m tied to development [...]

    Hikma produces generic drugs
  • Declining patent filings show Britain has stopped innovating

    April 3, 2026

    There are lots of ways to measure innovation, but if we go by patent filings, it's a sorry image for the UK, writes Ayushma Maharjan.

  • This may hurt: English High Court set for Moderna and Pfizer/BioNTech Covid battle starting today

    April 23, 2024

    The English part of a global dispute billion dollar legal case involving big pharma giants Modern, Pfizer and BioNTech over Covid patents, kicks off today.

Trending Articles

  • Why the Loire Valley is about so much more than fairytale castles

  • Why HMRC is huge Premier League transfer window tax headache

  • Thames Water faces fresh threat to survival after pensions regulation breach

  • Back to basics: Sainsbury’s gradual retreat from the British high street

  • Thunder Call set to Strike in Shergar Cup Sprint

MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook